Featured Articles

  1. 3 Reasons Optimized Trials Are Ideal For Pulmonary Research 7/18/2024

    Formulating studies to better meet the needs of patients is crucial for optimizing its success. This is especially important for complex trials, such as those focused on pulmonary and respiratory conditions.

  2. Diversify Endocrinology Study Enrollment With Optimized Trials 6/18/2024

    Diversity is a problem in endocrinology research, but Elligo’s optimized trial model is an exciting solution. Here’s why.

  3. Can Optimized Cardiology Trials Solve Major Challenges? 6/18/2024

    Discover the key challenges facing cardiology today, explore the benefits of optimized trials, and learn how they effectively address critical issues.

  4. Improving Diversity: Patient Engagement And Recruitment Services 5/13/2024

    Per FDORA, sponsors must submit diversity action plans for FDA approval. Luckily, these plans are easy to implement with this Patient Engagement and Recruitment solution.

  5. 3 Steps For Internal Or Family Medicine Clinical Trials Enrollment 4/17/2024

    If 25% of U.S. adults don’t have a primary care provider, how can you access enough patients to fill your internal or family medicine clinical trial? Here are three tips.

  6. Patient Engagement: Early Cancer Detection Blood Draw 4/17/2024

    Discover how we aided a pharmaceutical company in enrolling participants for a Phase III trial, DETECT-ASCEND 2, focused on Plasma-Based CancerSEEK Testing for early cancer detection.

  7. Can Patient-Led Clinical Trial Design Save Neurology Research? 4/17/2024

    What is causing high fail rates, and what are the best opportunities for sponsors to turn them around? See how understanding the factors can help sponsors navigate and improve outcomes in neurology clinical trials.

  8. The Easiest Way To Meet the FDA's Clinical Trial Diversity Requirement 10/20/2023

    Explore how this innovative approach to navigating FDORA streamlines the diversity action plan process while placing a strong emphasis on patient-centricity.

  9. 5 Ways FDORA Will Impact Clinical Research Sponsors 8/15/2023

    While the FDA Omnibus Reform Act of 2022 is slowly changing aspects of clinical research, explore five main ways studies are currently being impacted and what trial teams can do about it.

  10. IP To Treat PFIC Approved With Support Of Customized Research Services 7/14/2023

    Find out how this biopharmaceutical company was able to evaluate a new drug's efficacy and safety for treating progressive familial intrahepatic cholestasis (PFIC) in a pediatric patient population.